{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {},
    "annotation_url": {
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis",
      "version": "1.0.0"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
    },
    "namespaces_uncached": [],
    "path": "nfkb/srinivasan2015.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "key": "666aa93ba3e25b35ef5f10a4d8fcc224cf3278ea3eb2d040b69397b16b8d7d3e07b9c08e3564c42dfb28943982e2619983f76a766a441b43568582282111df1a",
      "relation": "hasComponent",
      "source": 32,
      "target": 5
    },
    {
      "key": "22922551148b6a791af4acddad4d7e26c77516ba7b3f1cba0372fd7bfe269805e721c8d7e475e9dacf3c8b0c7228c3c6e6baf67f9af7277e3d0f2c50322bf59d",
      "relation": "hasComponent",
      "source": 32,
      "target": 57
    },
    {
      "key": "1a34acf4a7f52b723b8236f9b25e1939b4ba4f38700b69358408e477f8a84c7c273f456e570cdd928f6698a830fff211d05b523aa526d686872da90b1217c9b1",
      "relation": "hasComponent",
      "source": 32,
      "target": 61
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "The constitutive form is transcriptionally active as evidenced by the nuclear localization of the p50 and p65 subunits in the neurons of the cortex and hippocampus",
      "key": "137cd72994934095ecb948f235d276519185927e65c26008569ad9c02b0f0cc4549f284b834acb6eb41f7cacde104f6aa1596b202aee416bc8b009d4cbce2c08",
      "line": 78,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 32,
      "target": 31
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Comparison of the cellular distribution of NF-κB in the nucleus basalis of Meynert of AD and control patients showed that the proportion of large cholinergic neurons with elevated nuclear p65 was significantly increased in AD, suggesting an association between NF–κB functions and the process of cholinergic degeneration",
      "key": "ea58219664aa683a4f173aaf8fcb9038e1fe4876ae971cedc8b1d7234dc96737276967d4a26457a275eaec66efb91eda237a54b3fbd880e1d12e8f639fd2b349",
      "line": 246,
      "relation": "positiveCorrelation",
      "source": 61,
      "target": 68
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "In conditional neuronal NF-κB-deficient mice, loss of NF-κB signaling impaired synaptic transmission, spatial memory formation, and plasticity",
      "key": "5c1d25481d9b535b766c681da30c38d361abf71ee98ec7d1f28f8a3ff3188a54fa342eae27116e2132989858b5e27f2f6a81d56780023b5dd5e5b71c22120f1a",
      "line": 83,
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 28
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "In conditional neuronal NF-κB-deficient mice, loss of NF-κB signaling impaired synaptic transmission, spatial memory formation, and plasticity",
      "key": "43ce3b611a43199fdf097ef8d7f39d869a3b0bf9a5132c045eff011b7537e32be728ddda42fe9fdbdba47930f52fff55fa8e662dfba911bc895359b57bfa8725",
      "line": 84,
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 70
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "In conditional neuronal NF-κB-deficient mice, loss of NF-κB signaling impaired synaptic transmission, spatial memory formation, and plasticity",
      "key": "f2d756ecc29205cd4fe63a379fd52bf8e0ff10bb6316f950bb988c63a4238c141185e28697fae6bbbd80d7aeed74df354f952f3eba31c939c1ac67b997a6b6b6",
      "line": 85,
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 25
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Complete abrogation of the DNA binding ability of NFκB factors induces apoptosis of the neuronal cells",
      "key": "1db837ac75681638b56dfe21933462f64aad39fb1276b753abbeb1e75b6ecab1ce2c77917072925a17f971d97ec8b62e6722f680dc64628e8968fd05e03011d5",
      "line": 97,
      "relation": "decreases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 16
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In primary neuronal cells, exposure to Aβ25-35 peptide increase NF-κB mediated transactivation of manganese superoxide dismutase (Mn-SOD), suppress peroxinitrite production and inhibit membrane depolarization, thereby preventing apoptosis induced by oxidative stress",
      "key": "62bfb1d4eb0c5bdd771337a5f4c47ed5bf840ba91ad524154520fcbc9b38aaa68d4d8ce9dd78e0a0b9d86530b8ae63a6fff1bdd5f8fa00aab7d525ce35af75de",
      "line": 209,
      "relation": "decreases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 16
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Cell death is preceded by reduction in the NF-κB regulated transcription of anti-apoptotic genes suggesting that a minimal threshold of NF-κB activity is needed for neuronal survival",
      "key": "c6b24794ec4d82bd543c26072fd93659650d23f45a283cd142e2b8e283d8a3057a9a3070d0258f042e6826ebf1321291644536b51eeb0f80e37952956fc94e6a",
      "line": 103,
      "relation": "decreases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 21
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neuroglia": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Various endogenous and exogenous stimuli activate NF-κB enhancing transactivation of inflammatory molecules and production of free radicals in glial cells",
      "key": "f7b007ce4fa87f029d009a8a024478fc0b3d478f836a7513c7d655e062637ab69f6661fb9e0fa97a0c92d6b2addf05241dc608769c137a74597ec47119589663",
      "line": 125,
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 19
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neuroglia": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Various endogenous and exogenous stimuli activate NF-κB enhancing transactivation of inflammatory molecules and production of free radicals in glial cells",
      "key": "0e9a48cd7cfd4f3b1f30c720e2c57b4a48e3e5389cce8ad956851db5eaf93121a71bb498bb05ca37af1794b8a7abfe58cf3050f31223ca860f548a3be755baed",
      "line": 126,
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 8
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neuroglia": true,
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "A consequence of intracellular and parenchymal accumulation of NPs and NFTs is activation of NF-κB in the neural and glial cells with subsequent protective or detrimental effects",
      "key": "98f10e78d9a579915b3e2f2af9121559b93c06ffab1530a404a1a35b7f04ac2b61a0de0310d4b52567be698297d029cbbfbd8164a6265304a7d6ce5ee4b6fda5",
      "line": 142,
      "relation": "positiveCorrelation",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 6
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neuroglia": true,
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "A consequence of intracellular and parenchymal accumulation of NPs and NFTs is activation of NF-κB in the neural and glial cells with subsequent protective or detrimental effects",
      "key": "1fa4f55b939265e19bca86aefe1f50f0d9e3636a8efe41e9a06b491cdd5ced01686d1624310282f7319778f919e7f7152902fa2d755c9df1d93cb8bd824281ee",
      "line": 143,
      "relation": "positiveCorrelation",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 69
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Increased presence of activated glial cells presenting elevated NF-κB and HLA-DR expression are commonly observed around the Aβ plaques in postmortem AD tissue",
      "key": "06f07aed8c038b60028f5691fe30e95023616425fda81088e5b717cacd8ae45246708ae9d5510064b8555fb590b63ba046e031a6a4075a821a6ee7df8820b10d",
      "line": 287,
      "relation": "association",
      "source": 30,
      "target": 69
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In neuronal cells Aβ1-42 peptide has been shown to regulate APP and BACE1 proteins in NF-κB dependent manner",
      "key": "4beba58bec0405c335eb3ee92726d81e0d0b09f9e9054716a3f795fa46ad144c2f40595994766cacf571835fa8b3f65f598604c63ad57fb3a33a249d08bb64cd",
      "line": 152,
      "relation": "regulates",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 46
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In neuronal cells Aβ1-42 peptide has been shown to regulate APP and BACE1 proteins in NF-κB dependent manner",
      "key": "3d253a614e9e050557806208a4d392217a68bd13e39e10d34bcc14a8f29aa976051ad5feac8149b9d8575b92e328a70514462292d93708ff71961022b4f81d75",
      "line": 153,
      "relation": "regulates",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 47
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Under physiological conditions activation of NF-κB by endogenous Aβ reduces βAPP, BACE1 and the γ-secretase activity, thereby lowering Aβ processing and facilitating Aβ homeostasis",
      "key": "a5cb1f47eb99cd0e94650d2a57c85387593fc113e8a788938d17a69d2fd37b80635c0c7f36a3f483fb81c5c6a750a62c1fd3715b6c2c7a23c5002ece1be64f44",
      "line": 162,
      "relation": "decreases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 47
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Under physiological conditions activation of NF-κB by endogenous Aβ reduces βAPP, BACE1 and the γ-secretase activity, thereby lowering Aβ processing and facilitating Aβ homeostasis",
      "key": "8652a316e0a7f7e5c95da46134cd52088715327b3c1c0cda3a3b55d03a09bfb6924348b0b5b32696030e9fdc3d0377d59d6b6f6b3573e1b15580dbf205d723f5",
      "line": 163,
      "relation": "decreases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 43
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " However in AD, exposure to high Aβ concentrations upregulates NF-κB activation increasing βAPP and Aβ processing, precipitating a feed-back loop that favor exacerbated Aβ production ",
      "key": "3cec20bf0760ef9cc861436bf6bbbce15ec54b5f9e4b18ef8881c5f231e82542c1d6b24246933b50cb31c82e0d1104771669f10149afa8d747e378b3410122bf",
      "line": 173,
      "relation": "positiveCorrelation",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 43
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Under physiological conditions activation of NF-κB by endogenous Aβ reduces βAPP, BACE1 and the γ-secretase activity, thereby lowering Aβ processing and facilitating Aβ homeostasis",
      "key": "0c69a77424338b91a3f5dd16ec060f257c9ca75215117355c4dc6e4b533ec33047e480a67d15b2a56c4db9671502f3da070e9faf232fa70ae5c587b68c2efcf0",
      "line": 164,
      "relation": "decreases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 15
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " However in AD, exposure to high Aβ concentrations upregulates NF-κB activation increasing βAPP and Aβ processing, precipitating a feed-back loop that favor exacerbated Aβ production ",
      "key": "fc71a7b1a790daf89cb4733b2d1a938846fc2959fa96ac3f0ca2b226f405a6ec700166682899e1a4d8b95e513fca561fcb8b8c10541113a929e0595935211a36",
      "line": 174,
      "relation": "positiveCorrelation",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 15
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Under physiological conditions activation of NF-κB by endogenous Aβ reduces βAPP, BACE1 and the γ-secretase activity, thereby lowering Aβ processing and facilitating Aβ homeostasis",
      "key": "bc968f412c4c88478fc5bd6ae29cc2cd29e66538d9cfcd8f5c532b45c242f1a160ced4324ae728d509d73270bdceb22167975f834375378713c7d09320e53a28",
      "line": 165,
      "relation": "regulates",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " However in AD, exposure to high Aβ concentrations upregulates NF-κB activation increasing βAPP and Aβ processing, precipitating a feed-back loop that favor exacerbated Aβ production ",
      "key": "d2510c9c21866f1a1f5d9d177a42d739f17ea916d2147fdd2ba52676ba7b5f5f055a8fcefc03297b04c6fb6c9fea909e901787b381599da57269862e00b15b22",
      "line": 172,
      "relation": "positiveCorrelation",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Astrocytes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Aβ has been shown to upregulate APOE in astroglial cells. This upregulation was inhibited by decoy-κB nucleotides supporting a critical role for NFκB in APOE function",
      "key": "a6c5774b8fd54ba40d37f58caabc147314b82d2aef7e464b76c6d31bbcd3b62bdae0e626f24efb32af3b6c2adb50772dd7a29525f6f22b9aef015eae7ad2b1f1",
      "line": 180,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 30,
      "target": 45
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Decoy κB nucleotides mediate cell death by blocking neurotrophins and anti-apoptotic factors supporting an essential role for NF-κB in the neuroprotective process ",
      "key": "eeee1f6c86855e2bf0bc41f6b6d9cd80080d0fb4982ce0ce9e98830e9d59c30f3705557b2242e1739536741790bd95b9e931990057425b4cc8e6e91d1c89c805",
      "line": 199,
      "relation": "increases",
      "source": 30,
      "target": 29
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "These NF-κB mediated neuroprotective effects have been largely observed in early stages of neuronal regeneration in AD",
      "key": "7e041e195632dde507878b0c00b45fba532260e342b383027503c69abd77c35129e12e476322d6522280ca91c02181b168a4b5b789b3ce6c58cfe99c012a0029",
      "line": 227,
      "relation": "regulates",
      "source": 30,
      "target": 29
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In primary neuronal cells, exposure to Aβ25-35 peptide increase NF-κB mediated transactivation of manganese superoxide dismutase (Mn-SOD), suppress peroxinitrite production and inhibit membrane depolarization, thereby preventing apoptosis induced by oxidative stress",
      "key": "608ba846342c14155319556a3697bdc6f4de4255da2e1bc88b89cb915e19508038a9eef6d62b6927681dea1fd6e8f23203816fc7d0b017991b0af6813da3f980",
      "line": 206,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 62
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In primary neuronal cells, exposure to Aβ25-35 peptide increase NF-κB mediated transactivation of manganese superoxide dismutase (Mn-SOD), suppress peroxinitrite production and inhibit membrane depolarization, thereby preventing apoptosis induced by oxidative stress",
      "key": "d7fc083888b663ef6a6f6fe9b049478a2b0d3c79ca977f52f6067741a7a59b9030f2d87b4541de33eef279f4b236bc14e4e0ab8fdb9195094d032772dba53ef5",
      "line": 207,
      "relation": "decreases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 4
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In primary neuronal cells, exposure to Aβ25-35 peptide increase NF-κB mediated transactivation of manganese superoxide dismutase (Mn-SOD), suppress peroxinitrite production and inhibit membrane depolarization, thereby preventing apoptosis induced by oxidative stress",
      "key": "992e21a07b840ffe8f15f8387e9fddb9b1d765e99bbe5b45c630dd0af54bca59091fda69c568dcfd23aebdaa578c10af00f0f6251fe422b3d1a3d86694b421ac",
      "line": 208,
      "relation": "decreases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 20
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Comparison of the cellular distribution of NF-κB in the nucleus basalis of Meynert of AD and control patients showed that the proportion of large cholinergic neurons with elevated nuclear p65 was significantly increased in AD, suggesting an association between NF–κB functions and the process of cholinergic degeneration",
      "key": "b3dc4272cf71a18855bf91ae618b8584b9f589b202a1610aff3ae3362f65439fe5b93c3a36ff7e56eb834541a056e6963932f777f08e4f957e7bdf2a483d7085",
      "line": 247,
      "relation": "decreases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 7
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "These observations substantiate a direct role of neuronal NF–κB activation in the pathogenesis of AD",
      "key": "125e606093866e1a3cdf0b595f97d3d1143f5b15714591b432089eb34136bd430c4932aaed99ca7a94d07078308616fce2c019d3c61c91bdb2f5d5e8ee60e500",
      "line": 261,
      "relation": "positiveCorrelation",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 68
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Increased presence of activated glial cells presenting elevated NF-κB and HLA-DR expression are commonly observed around the Aβ plaques in postmortem AD tissue",
      "key": "5647095f4dca61b57d75cba3f109b5ca52b177859af14c0f43d0cab7990e77e6d6dc15d093e4836508ac76edaab1a4b0d3d5ffb616c0064490c566e1706e2eea",
      "line": 288,
      "relation": "positiveCorrelation",
      "source": 30,
      "target": 68
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "5e0d6fd594b5ca0c1108f334f35633a41bc2607788d1c920b1dffca043f5ed6a7e80844da54dc248c8a14070b0fc0cd274c11f6d378132454f2593d33bfde712",
      "line": 298,
      "relation": "positiveCorrelation",
      "source": 30,
      "target": 68
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "c59fca4ab6afb41acd3cf0681ac09f364f4e9f497b978aaf9f994c30ee1e670b475ab83ce1baeee582a257c077fb71d1e636babb359faaf1cac15289600fea7b",
      "line": 278,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "03946f0965d1577684709e71dfab4157b2d3d62be74948eed80e7c305c35a220b802785711aeb6c7ed32bafea49ca78d4e7480e299f234b89fa7eaa9d2265397",
      "line": 279,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 13
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "89d48e21ffdf88a74d3ea210f8219a5ebb9d095595bda5aff5cc59cbda2eba8440dcedf19ac493e76f6bd304fd62c56a6f90e1fdcdb90f8b5075c80539a7a5c4",
      "line": 280,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "6e612b23761b856d5d4ce01e5af0d63cd81327fbc1bb46da9f0a3a57a6247a97a685a56e4a3289193d7a6c8a06a879bb24ddaf39d1e8ab45737925cb848b7ee4",
      "line": 281,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 3
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Furthermore NF-κB specific inhibitor prevents iNOS and ROS upregulation in Aβ stimulated cultures of astrocytes or mixed cortical cells",
      "key": "d35c7d6f92aca1a12b3e9a1938a4a5b14a0548e4c6a6abbdf5487d9d0295b3b9be23539390e963e6bd1c87a728513034633e6d8542a3f59af2be95ecdbdd8080",
      "line": 314,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 3
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "ffd0d695551167367be8d2895e9efe20b3f8d1213e34cdcd212d54e2dc1a43c3d582b5222a5ef521642f215934d6e83a79dcdb6e24fce590139e85047c93c838",
      "line": 282,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 59
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Furthermore NF-κB specific inhibitor prevents iNOS and ROS upregulation in Aβ stimulated cultures of astrocytes or mixed cortical cells",
      "key": "30d682ab4d966c83489b10aca3e1159cfc2e0dc437a39a33db4f4a829b97e1d0eabbc12401d44f011679df4a9eb6d6e05a3b21e0fbe1866c46199c91f9fb3263",
      "line": 315,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 59
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "d94ea94b4ae268344fff106e650c9ad2122cff2e8328e8c2eff203aca870a7ab10940e2f9d6908626dfdb78ae6dbb9fa3a6659a7b5b245b218a62cc0dc98fab0",
      "line": 295,
      "relation": "increases",
      "source": 30,
      "target": 55
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "cbec68492070f9feb2b672b23a24491d03b87671fc6935c99477cf0b77845dd9bdfc1ff67dc45828495ffb3a119d4e8de6185c8e9c36be4938c6c09c6be2aa38",
      "line": 296,
      "relation": "increases",
      "source": 30,
      "target": 56
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "8c3ca005ad9ce4a8d7fd7d5ef55d859b0e948659096dbe2eca347624401e46314b53f9faad22bd3ecd6e0d7a014558e4519488824faf529659642a6bc94c2a1f",
      "line": 297,
      "relation": "increases",
      "source": 30,
      "target": 63
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neuroglia": true,
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "This is supported by the observation that in mixed neuronal-glial cell cultures, Aβ induces increasing degree of neurotoxicity in an NF-κB dependent manner in the presence of higher proportion of glial cells",
      "key": "06a9cb7032311a82db2a1180c008e37fb5acd21aec374e92f3bdb17cf8fea4a14f9ca3e560553ae2e6e22c6e1f7487ceb779ee05106fde13d865c973063a76a7",
      "line": 309,
      "relation": "increases",
      "source": 30,
      "subject": {
        "modifier": "Activity"
      },
      "target": 67
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "664ff7fa1ce0f9bad486421554893c70ded7d53d80e58ab15db126199fc2e6d934ecad9568dacbaae99f14b077fb146951e644ba60d597d960be09f57e9d2302",
      "line": 321,
      "relation": "regulates",
      "source": 30,
      "target": 37
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "0851297bea5992a467d079ced1dc1c2313146333e2cd6d6ae92d7f5a0959917817a47cb8d83a80e493e0911eb97f7f575a069e8a176ec1240898b84b61f84523",
      "line": 323,
      "relation": "regulates",
      "source": 30,
      "target": 42
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "202c567ec3da202c4f5a1c6db8ec585f6c41f23db8a85887871b3939b0f27284a5eb85d50eb58ba408c9a762c4e829d57483bbe8f6d1a086f4425ec1f8f19102",
      "line": 325,
      "relation": "regulates",
      "source": 30,
      "target": 38
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "06577713ef2eaeba21e4cdc7a18c103865f014b6a60e0467f78045f9c3fc87986c3308ad6afe282d03aae3dd770ca9e9c265291c4ce7ea2025989487229c8356",
      "line": 327,
      "relation": "regulates",
      "source": 30,
      "target": 39
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "2790badcc3f1bfcf68aee9b2778d38bd166472cabe897665b5927affd40be2fe35a2fa78d39f16c5a2083a9a7703819501314fc113ca4a5834847bb0b0d6cd47",
      "line": 329,
      "relation": "regulates",
      "source": 30,
      "target": 40
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "f96ac7b73f2d76240fd0a4bbf07197a2dcea8b29cf8dd1cbf6d135bb4d4977a94a711ac092c4c03b61dccbac3af43ab50723d5f7375f8f5868d2ff4be1b817ff",
      "line": 331,
      "relation": "regulates",
      "source": 30,
      "target": 41
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cytoplasm": true,
          "Dendrites": true,
          "Neurons": true,
          "Synapses": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "A number of physiological stimuli including membrane depolarization or glutamergic signal transduction lead to rapid activation of the inducible NF-κB localized in the synapses, cytoplasm and dendrites of the neurons",
      "key": "93a28235ef62a9c12cda99e50c7df7b773d1d1c43857fd6194d32b265aec94e0a1d38e7f2988a1115e6edc7a7aadf6c16bf77a658d7034abf75c6cab6d85bbb1",
      "line": 91,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 20,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cytoplasm": true,
          "Dendrites": true,
          "Neurons": true,
          "Synapses": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "A number of physiological stimuli including membrane depolarization or glutamergic signal transduction lead to rapid activation of the inducible NF-κB localized in the synapses, cytoplasm and dendrites of the neurons",
      "key": "05e21544cc358ed6dfedea39fe87698a147d6db6e3e32dd45c22c63bfb2b0f65eaa0e5724671ad75172ac6240844f3fbaa41a8c4747704529f7b6195483d70f1",
      "line": 92,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 26,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Several kinase pathways including the calcium-calmodium dependent kinase-II (CaMK), the protein kinases-C (PKC) and the ras/phosphatidylinositol 3-kinase (PI3K) pathways have been implicated in activating neuronal NF-κB signaling",
      "key": "1e307764cf3b7db860a02bc2411a5f91220ae71d0c3563ecb01dbe74ecd76f858b6b87de8068c281ac741928deedd68c23fa14e3d68cecc3ad19a197e41f4d70",
      "line": 110,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 17,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Several kinase pathways including the calcium-calmodium dependent kinase-II (CaMK), the protein kinases-C (PKC) and the ras/phosphatidylinositol 3-kinase (PI3K) pathways have been implicated in activating neuronal NF-κB signaling",
      "key": "91c139f23a5efae7fd707666515228a048af61c5945ec5793f7363b11f47da447a3299cce5581f79aeada0f77ac7a209c89cd783a4f420bd86cf099da81559ae",
      "line": 111,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 44,
      "subject": {
        "modifier": "Activity"
      },
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Several kinase pathways including the calcium-calmodium dependent kinase-II (CaMK), the protein kinases-C (PKC) and the ras/phosphatidylinositol 3-kinase (PI3K) pathways have been implicated in activating neuronal NF-κB signaling",
      "key": "452fde4c2f0104aa5aaba8eba8aae9e37092de8c4ed13de966a5f693b375d49a6f027e63b5d3fef07ab5b7b6f9d7001f870bbec5f895cb1ca91889b761f4d28f",
      "line": 112,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 23,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cytoplasm": true,
          "Neuroglia": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Unlike neurons, NF-κB is present in the cytoplasm as an inactive complex with the IκB proteins in glial cells under physiological conditions",
      "key": "6231798e00ee90f1ea776bf19d675996b0bd3b2df871cfc8b5c64dcc08e2a016327fd2940c4bcb0b65499ba6a9ce2abcabb1052c7c2f38b7b04000ed4c2df53e",
      "line": 118,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 10,
      "target": 30
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Glutamate induced stimulation of cerebellar granule cells via the N-methyl-D-aspartate (NMDA) receptor activate p65:p50 dimers and enhance transactivation of pro-apoptotic factors",
      "key": "c5877e31e121cdd8c05585f446100abf3f1eb6810b9a896988398e3253ab2a904bde69acec2e92ae96d88b8ff123ebfb0516abf986ebd26279cdacbb284251ee",
      "line": 131,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 2,
      "target": 11
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Glutamate induced stimulation of cerebellar granule cells via the N-methyl-D-aspartate (NMDA) receptor activate p65:p50 dimers and enhance transactivation of pro-apoptotic factors",
      "key": "17e17e723272c2317e8a63d2274de953fb19247bb80c4b357ad4eb46200d3b72c1254d7d040fde39c499a9e83e900e3733345612cbef4da9334e5079f62356f2",
      "line": 132,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 2,
      "target": 35
    },
    {
      "key": "e81bff474261fd593752f7dd4f5d9b9df44c76dde8387e02fa50f6af9cb976f0c1f51db0ed1957978cb17299da469595975c957604ec2534636cc045145b2401",
      "relation": "hasComponent",
      "source": 35,
      "target": 57
    },
    {
      "key": "95a01684e27270e585bd64cf61e42cfcf8e0de789dc26a82dd3f8cabf352ea71a09d30d186b8187d64df7a0457f8540d7c60fc27bea698c1fea0624171393d57",
      "relation": "hasComponent",
      "source": 35,
      "target": 61
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Glutamate induced stimulation of cerebellar granule cells via the N-methyl-D-aspartate (NMDA) receptor activate p65:p50 dimers and enhance transactivation of pro-apoptotic factors",
      "key": "725b3996ebf218d7a03c18f3648bb036d191acf48948844d656063d2cb78fdc2696a558e9d8cfafc05e43e514881059cc835c902ab199a0cd10c42fee53262aa",
      "line": 133,
      "relation": "increases",
      "source": 35,
      "subject": {
        "modifier": "Activity"
      },
      "target": 16
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neuroglia": true,
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "A consequence of intracellular and parenchymal accumulation of NPs and NFTs is activation of NF-κB in the neural and glial cells with subsequent protective or detrimental effects",
      "key": "b1707c553e9fc3a84c48abacd957850bfa1baab58c8d4960d24787ea3c2125864b0e25601d2f39d11fcc500d7831a654f65690e07d856d51d9d0b3f7d9667372",
      "line": 142,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 6,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neuroglia": true,
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "A consequence of intracellular and parenchymal accumulation of NPs and NFTs is activation of NF-κB in the neural and glial cells with subsequent protective or detrimental effects",
      "key": "a6d610463b3ac260071c9c7f898a221d54e2159dfd7780e342a8723a70d4f1833198a32a5621c7a82778ff31d474bb6d62bb3ae39751daf26d279930c9bfed2f",
      "line": 143,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 69,
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Increased presence of activated glial cells presenting elevated NF-κB and HLA-DR expression are commonly observed around the Aβ plaques in postmortem AD tissue",
      "key": "104a2bc4001bc5ccbbc1a92d03ebb0e4031c304502ac6c1fd48f17b56600de21079072f1c172580d39462a5910f30cd414b0ab3562f74906026c61361904a436",
      "line": 287,
      "relation": "association",
      "source": 69,
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Increased presence of activated glial cells presenting elevated NF-κB and HLA-DR expression are commonly observed around the Aβ plaques in postmortem AD tissue",
      "key": "6e749cbbbfde3c44dd143d8a737c740bdd8a99cc0472bbb2e8fa731c297b6251e4d1f5f9045199d4d02da70526708b5bd01f428bbe8fd4576ca94fbe3960f03e",
      "line": 289,
      "relation": "association",
      "source": 69,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In neuronal cells Aβ1-42 peptide has been shown to regulate APP and BACE1 proteins in NF-κB dependent manner",
      "key": "ef7294c1d1cc87cd9d4067f1425866d2be445d25bad9615bf642dfe3d92fcdb93788b7b4780ea155e58b6d638c9c694d950f8248f6fe6fae86c3d4ab996e198c",
      "line": 149,
      "relation": "regulates",
      "source": 0,
      "target": 46
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In neuronal cells Aβ1-42 peptide has been shown to regulate APP and BACE1 proteins in NF-κB dependent manner",
      "key": "be6d59f46897634560a8ba888972c8e73b73fb6fb0da569d3e845f23cbf7af9d5e810afe626cf928256793fba390f70b0785888c6398c31feea01faefef936c1",
      "line": 150,
      "relation": "regulates",
      "source": 0,
      "target": 47
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In neuronal cells Aβ1-42 peptide has been shown to regulate APP and BACE1 proteins in NF-κB dependent manner",
      "key": "5fedb5ac8850bb9dfa84e18334cbb45971f6ca80207c90d5e29999e84e193bfb53276e74105612c49159ef0c1ab157afc5db0ca5c4160cb478a5dd9dd51a415b",
      "line": 151,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 0,
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "7e8119618fa23f0c8fc0e872fec9f03ac6865f79fc97cf086dafd738554a562383e8f0b76e3d1b74e7846f964c2c689bb62018538e9bcee65d405169a1dc0df7",
      "line": 277,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 0,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Exposure of primary neuronal cells or post-mitotic neurons to Aβ1-42 peptide has been shown to strongly activate the p50:p65 dimers and mediate neuronal cell death (Fig 1)",
      "key": "35603a137606bf987b66a0b5dec881f7ba966966c52502607411757c24625aa829cbc114b2eff4231dd6e8828610fb933d0859afdc12d4c5c695ab3a107ffc15",
      "line": 232,
      "relation": "increases",
      "source": 0,
      "target": 35
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Exposure of primary neuronal cells or post-mitotic neurons to Aβ1-42 peptide has been shown to strongly activate the p50:p65 dimers and mediate neuronal cell death (Fig 1)",
      "key": "3f8a409b2f2dbe3b8e55c36c296ea04bdada0773ecd1117b7f82c385f8d188ace1783b4c1d48a9dea7050e9055338c7c7a92002f67f60ea36903ab7fe53f356f",
      "line": 233,
      "relation": "regulates",
      "source": 0,
      "target": 18
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "596fbec6d991b9b3ff44708e4404423a881a1de831b5b1b0b1252aede757d9878d0920a6b980a38522085ee9409b91083dd5c567e84be07802148d2bad8c241d",
      "line": 270,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "4629329a5f31c94ed9b9dc8067ec3e9d276847831746dc1bcc4e4d9f8bca630e71d6c03049c7e7923d1ebdccc1fbb1023cbdec246bbd7610a0e0cd47db95517f",
      "line": 271,
      "relation": "increases",
      "source": 0,
      "target": 24
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "366883a71b7fe170af79afc03f4e6b9a337f8e69a4cb7f75010d7f03e3d7fd635dad346201ab67ca97c78e857b21d5a71e998fa19045c9d5fa8691e81ea113a5",
      "line": 273,
      "relation": "increases",
      "source": 0,
      "target": 22
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "b57d34ad9e608c664eb4f07ae1b21047feac691a28d01409250c88c7098aac2c2fbb7af5f56cf97dca9a5cbfe063e855c351a11201ee6e1d3ce4a3d41e1960fd",
      "line": 275,
      "relation": "increases",
      "source": 0,
      "target": 66
    },
    {
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Under physiological conditions activation of NF-κB by endogenous Aβ reduces βAPP, BACE1 and the γ-secretase activity, thereby lowering Aβ processing and facilitating Aβ homeostasis",
      "key": "a7f1945587eb1376455b27022ed7e4dc31b274e99142c32dc11fa10b55707dba7110d240b9c53deac3f354ce4878ecaec8793680677ee7190c9cc38d6d398651",
      "line": 161,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 1,
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " However in AD, exposure to high Aβ concentrations upregulates NF-κB activation increasing βAPP and Aβ processing, precipitating a feed-back loop that favor exacerbated Aβ production ",
      "key": "bce2aea2e6679d3aedfa8f7b8f5d87d694288095baf51efb60bedc523bb746738069311f652cb5bcdc7a9809cce10e5028901bfb13655d5f0b167bc4e29caafc",
      "line": 172,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Mechanistically, the Aβ induced neuronal apoptosis has been attributed to the increase in the ratio of proapoptotic gene (BAX) transcription to that of the anti-apoptotic gene Bcl-Xl, and/or to the reduction in constitutively activated NF-κB with consequent increase in the cytoplasmic IκB proteins",
      "key": "a94888bfb54cbf3090e16e9358adeb7b12f4478c87ba7380f261c7208c4343d673caf32f792aa247f0cbbbdc5db93ab9b44c6e28f350aab6b7bf5d4c6430be8a",
      "line": 255,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 1,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neuroglia": true,
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "This is supported by the observation that in mixed neuronal-glial cell cultures, Aβ induces increasing degree of neurotoxicity in an NF-κB dependent manner in the presence of higher proportion of glial cells",
      "key": "74534872e2a4c34dd206abc323aa8109bb32abd51cc5e9c99ea6d70a3e4dff9ab207a92dd8bd3c0ab55b8491565089bbacb32135fc222e04db5f2352dda71642",
      "line": 308,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 1,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Astrocytes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Aβ has been shown to upregulate APOE in astroglial cells. This upregulation was inhibited by decoy-κB nucleotides supporting a critical role for NFκB in APOE function",
      "key": "11e2c5e19b153becf743c75c517107d4bfc36308c846f5ef225bebf071d50dbdfffcb8500f1f75757c21e04d15744cfec16dcb90e78a18032a497760cd4b8315",
      "line": 179,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 1,
      "target": 45
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Mechanistically, the Aβ induced neuronal apoptosis has been attributed to the increase in the ratio of proapoptotic gene (BAX) transcription to that of the anti-apoptotic gene Bcl-Xl, and/or to the reduction in constitutively activated NF-κB with consequent increase in the cytoplasmic IκB proteins",
      "key": "18f51978b48406cb105fa4426fbda8618d0c5c4b2f13d0d9aba6c9eb3acee092b92d5b59bfc2ffc0d8361e40ba0eb584b1c7b22898c6e8b9cbbd88d3f0369be7",
      "line": 252,
      "relation": "increases",
      "source": 1,
      "target": 21
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Mechanistically, the Aβ induced neuronal apoptosis has been attributed to the increase in the ratio of proapoptotic gene (BAX) transcription to that of the anti-apoptotic gene Bcl-Xl, and/or to the reduction in constitutively activated NF-κB with consequent increase in the cytoplasmic IκB proteins",
      "key": "ae8c3678d29e5527d3e9788ec3e7212b348b6e500cbb6eb30d2ef7e5996aa81f777e3fe227ab9dea368f83b2dd2d5a7a44667252d08fe924445d027672ed7a64",
      "line": 253,
      "relation": "increases",
      "source": 1,
      "target": 48
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Mechanistically, the Aβ induced neuronal apoptosis has been attributed to the increase in the ratio of proapoptotic gene (BAX) transcription to that of the anti-apoptotic gene Bcl-Xl, and/or to the reduction in constitutively activated NF-κB with consequent increase in the cytoplasmic IκB proteins",
      "key": "b8545bcafa93061fe434ec97b273f753562da6af0fe9f093624ccccafc20f881482da18a773d212f94b1cca095f28b772a23b61b1f21b8d17e89dec13b2dda18",
      "line": 254,
      "relation": "decreases",
      "source": 1,
      "target": 50
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Mechanistically, the Aβ induced neuronal apoptosis has been attributed to the increase in the ratio of proapoptotic gene (BAX) transcription to that of the anti-apoptotic gene Bcl-Xl, and/or to the reduction in constitutively activated NF-κB with consequent increase in the cytoplasmic IκB proteins",
      "key": "b4958cf562133aa84b9ca2bbcc63a8dadbf46b2ce57800e8b80defb2060d254794ed17511c47cb61c30e0462a360226c44ff41b3f264d2ded40ebd85557ceeaf",
      "line": 256,
      "relation": "increases",
      "source": 1,
      "target": 10
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neuroglia": true,
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "This is supported by the observation that in mixed neuronal-glial cell cultures, Aβ induces increasing degree of neurotoxicity in an NF-κB dependent manner in the presence of higher proportion of glial cells",
      "key": "6cb64997f90e636c1deb6d5b9355c80c898d061351c992de1e56a21628caa427ee13ab1acc10f30ced96bd27535790a8e8fece7d052046dac9992b194985152d",
      "line": 307,
      "relation": "increases",
      "source": 1,
      "target": 67
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " However in AD, exposure to high Aβ concentrations upregulates NF-κB activation increasing βAPP and Aβ processing, precipitating a feed-back loop that favor exacerbated Aβ production ",
      "key": "5a70d2f001f6dcd69ef3a7d7faa0b286a1a585c9a7e7179c982718fe46dc5ef8c1cb6c856b6035c051cab2230a5789e9924e75d5e239698e5cf5297d9b1f9a15",
      "line": 173,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 43,
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " However in AD, exposure to high Aβ concentrations upregulates NF-κB activation increasing βAPP and Aβ processing, precipitating a feed-back loop that favor exacerbated Aβ production ",
      "key": "a669b3e2207774237f28d8e502232cfa7e834a5e937c18494aa502bb135e3897c4a347467940026dc73e524cd1554e5a193cdbdc12a71fb46413df0650083f52",
      "line": 174,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 15,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Astrocytes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Aβ has been shown to upregulate APOE in astroglial cells. This upregulation was inhibited by decoy-κB nucleotides supporting a critical role for NFκB in APOE function",
      "key": "4b77cc16789bbc1feb09a56158a7df8850786124bc3002efbaf7b1ed716d9c1c0345999e4bc9ab24e61e8556fb92c6d5b0cadacd1119ded4cbeef734988ae860",
      "line": 180,
      "relation": "association",
      "source": 45,
      "subject": {
        "modifier": "Activity"
      },
      "target": 30
    },
    {
      "key": "dd8c225bfe1d6db29478c61c6e3f6f4bbfc79707fe7e729c5a2c2c298a29c10a5bc3695d73a41489a7abaa6fb4f05ba6d733aec67bd3bbd680fe84069d640d26",
      "relation": "hasComponent",
      "source": 36,
      "target": 12
    },
    {
      "key": "0d50eae09fb2ebd24d798963b659999b7e817dbf41d776cb07f8694658711d842f86556e12fca4082da3ec4645c70b6e4430c947033edf70fc40e5650e382a5a",
      "relation": "hasComponent",
      "source": 36,
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Stimulation with the Aβ25-35 fragments induces secretion of cytokines such as TNF-α and of neurotrophic factors such as nerve growth factor (NGF) and brain derived nerve factor (BDNF) in NF-κB-dependent manner",
      "key": "f9f84e47522b6faf29f6421b9d936614b1552575566931a02c37ddf7337b56b2646795634d8341c0bc3cce285d9ba7dc5e370a8e0c7e6d77a84a1509a582f791",
      "line": 186,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 36,
      "target": 63
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Stimulation with the Aβ25-35 fragments induces secretion of cytokines such as TNF-α and of neurotrophic factors such as nerve growth factor (NGF) and brain derived nerve factor (BDNF) in NF-κB-dependent manner",
      "key": "fbacf723079bfd6de0e8e964188825d82f514d7f0abf5a7d5909e8edcd998449cb8adf16500f7e7080bc830778bfa996a3ffb263017b54cf425f2cb5c15193c3",
      "line": 187,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 36,
      "target": 58
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Stimulation with the Aβ25-35 fragments induces secretion of cytokines such as TNF-α and of neurotrophic factors such as nerve growth factor (NGF) and brain derived nerve factor (BDNF) in NF-κB-dependent manner",
      "key": "bb3f811b16899ce9935f3159dadc42860fcde161b4ea06ec4a06f4ac9b17a2d3b7ed78121f0d9e2dbc7c79af13070ac59241bb74ec96ff8ef2f34d43b63935d9",
      "line": 188,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 36,
      "target": 51
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In primary neuronal cells, exposure to Aβ25-35 peptide increase NF-κB mediated transactivation of manganese superoxide dismutase (Mn-SOD), suppress peroxinitrite production and inhibit membrane depolarization, thereby preventing apoptosis induced by oxidative stress",
      "key": "c3354d623b1199151142afea4ad5947066374b88d056e9732b4d29022b9e92347dcf5d4a595dfc3ec279650eb37bf6fa98d26a6c13d83922cf0f956ceee126b2",
      "line": 205,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 12,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Stimulation of neuronal cells by TNF-α has been shown to upregulate transactivation of anti-apoptotic gene products and neurotrophins such as Bcl-2 and NGF respectively",
      "key": "1ab701139598ff4d14e2d9b0adc0fc357351b64e7026a35e18547b11888ba0ac4197170ec18733bdb4d881ebc1bbe66601916129b2bc701171498b0eaaafc1bc",
      "line": 193,
      "relation": "increases",
      "source": 63,
      "target": 58
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Stimulation of neuronal cells by TNF-α has been shown to upregulate transactivation of anti-apoptotic gene products and neurotrophins such as Bcl-2 and NGF respectively",
      "key": "0dc035f29e8094e11929377405c443086a222fbf7b4088741c3acfa6cdf5f4152fce5d9b45fa617032438d3c5b023bc36713a0ada2d64decf33237e90d78e38f",
      "line": 194,
      "relation": "increases",
      "source": 63,
      "target": 49
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "2c46a76326ad2a54080327ae63ed7d18249720479ad13f11da51c6455490dd311e7f7262f751e82e076fe338ba10ec8271300007a0b122e125118b3d52df3961",
      "line": 301,
      "relation": "positiveCorrelation",
      "source": 63,
      "target": 68
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In metabotrophic glutamate receptor-5 (mGlu5) agonist pretreated primary cortical neurons or neuroblastoma cells, Aβ induced toxicity was suppressed by selective activation of c-rel containing NF-κB dimers and transactivation of anti-apoptotic genes, Mn-SOD and Bcl-Xl [26] (Figs 1B, 2A)",
      "key": "7550004287e79896529ef6f3f08bf8fde84ad3d4aef5195bb37b7f4dd6405705f90127f21ee410096c795d3f0c23d6f07f451c08857d7710dda799f817da4290",
      "line": 221,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 62,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In primary neuronal cells, exposure to Aβ25-35 peptide increase NF-κB mediated transactivation of manganese superoxide dismutase (Mn-SOD), suppress peroxinitrite production and inhibit membrane depolarization, thereby preventing apoptosis induced by oxidative stress",
      "key": "e7d35bc9375f2c8f656fb8c3561e1639357b510d8c3b466846e2671e8859ff5b573debdbdc01baa10c44a0387a357168a7280a2d03190c791a8d8ffb815ed26f",
      "line": 210,
      "relation": "increases",
      "source": 27,
      "target": 16
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In metabotrophic glutamate receptor-5 (mGlu5) agonist pretreated primary cortical neurons or neuroblastoma cells, Aβ induced toxicity was suppressed by selective activation of c-rel containing NF-κB dimers and transactivation of anti-apoptotic genes, Mn-SOD and Bcl-Xl [26] (Figs 1B, 2A)",
      "key": "46236f55bfd6c0d56d4c17b91cf3be9ef370c04d78bea2d547977991dc97c35c3cda80f4863e2b18a160a1c18932337647864e9ff8ee9d9008aef8df190a012f",
      "line": 217,
      "relation": "increases",
      "source": 54,
      "target": 33
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In metabotrophic glutamate receptor-5 (mGlu5) agonist pretreated primary cortical neurons or neuroblastoma cells, Aβ induced toxicity was suppressed by selective activation of c-rel containing NF-κB dimers and transactivation of anti-apoptotic genes, Mn-SOD and Bcl-Xl [26] (Figs 1B, 2A)",
      "key": "7811f8b5d0e539eca448ea5a8c55a924ff84dc38715884f2f23c551be0984fc57fe211233aca91f3a4d5f5827ad0508e05737e315f9a8d2fe56614316a650f9a",
      "line": 218,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 54,
      "target": 62
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In metabotrophic glutamate receptor-5 (mGlu5) agonist pretreated primary cortical neurons or neuroblastoma cells, Aβ induced toxicity was suppressed by selective activation of c-rel containing NF-κB dimers and transactivation of anti-apoptotic genes, Mn-SOD and Bcl-Xl [26] (Figs 1B, 2A)",
      "key": "227222032a71c76cecfc249e6d452e190cb0e0388c14c45010e8067b22223b0a52f5df72e8782dc6ed210564b9e1bcbff12a33d24f3ad47758df8abcd6b16f5a",
      "line": 219,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 54,
      "target": 50
    },
    {
      "key": "32a3a42ce539fcfc399a66253db4fdb42019c57621de1d78a18bf40aff235f6ce44c2886eed3aac801f87628392893f68c7c610a7d533118d62bfc73104ebb53",
      "relation": "hasComponent",
      "source": 33,
      "target": 5
    },
    {
      "key": "52a8d28cfbba05d915edf890b42f79f0a78a21c9d04a0f4a50ca4cd94a1d5dc0e0ade8f286271aa90c353f7517b7694d53035d6fadfc522f65da9fe5a5d8ed52",
      "relation": "hasComponent",
      "source": 33,
      "target": 60
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In metabotrophic glutamate receptor-5 (mGlu5) agonist pretreated primary cortical neurons or neuroblastoma cells, Aβ induced toxicity was suppressed by selective activation of c-rel containing NF-κB dimers and transactivation of anti-apoptotic genes, Mn-SOD and Bcl-Xl [26] (Figs 1B, 2A)",
      "key": "69ebee09151ab4e60fd5246c6ee65d010394f98ee0c5b835ad949af7bfbbb26d2b23de0ac31fc7f43fc70f0abbf23ca33d5e4c7ce0a2945e9b4825ff5112b3f7",
      "line": 220,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 33,
      "target": 1
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " In metabotrophic glutamate receptor-5 (mGlu5) agonist pretreated primary cortical neurons or neuroblastoma cells, Aβ induced toxicity was suppressed by selective activation of c-rel containing NF-κB dimers and transactivation of anti-apoptotic genes, Mn-SOD and Bcl-Xl [26] (Figs 1B, 2A)",
      "key": "970f2e3464130a2c0d614bad0a66997afe7aa21f753d4ae25a10e1669a6fe304d4ccd472844240de215b666227a3627e4d7bd46bf0ac147e82a4c7de2dce8878",
      "line": 222,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 50,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": ". Consistent with the cellular studies, increased immunostaining for NF-κB-p65 has been observed in neurons and their processes in the hippocampal formation and entorhinal cortex in AD ",
      "key": "b88ef7c9ac13d4e9c59a963b7fcad2a2106cd85f5ffc1f2e512e05d60d1a08c9f74205bca8c6166a171a2805a529815a9510392b2771af05d99f930083df0693",
      "line": 239,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 34
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Comparison of the cellular distribution of NF-κB in the nucleus basalis of Meynert of AD and control patients showed that the proportion of large cholinergic neurons with elevated nuclear p65 was significantly increased in AD, suggesting an association between NF–κB functions and the process of cholinergic degeneration",
      "key": "146ae7ba0f9c779e9c6366654e1db17b32aac4164411471a8d08cc6ef4cbadfaa63d2bc217991d5662db4c3922d691e819134b0525ab949ce5466c89df3c5b91",
      "line": 246,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 61
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "These observations substantiate a direct role of neuronal NF–κB activation in the pathogenesis of AD",
      "key": "c1ae64e89f97b2079dede14ebabd40c817cd7048def7e4ec9f23030f849ce09c29143425c4290c3b4ce49256046d9bfff863a7d2a8f5c19a96bd0012a4f0253f",
      "line": 261,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Increased presence of activated glial cells presenting elevated NF-κB and HLA-DR expression are commonly observed around the Aβ plaques in postmortem AD tissue",
      "key": "71f82801fc52e9e013609416206d3de6cd03c69aaf5cab73de82b0b2c39d47e0dbf749f7cb187f675787ecdd3eb89bb8654e3086027cebd9f351a14af223339a",
      "line": 288,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "245a07d931bfcc3788d76097a52e1be891db9d5843662a8fb4b476157627e84a0d699b2eb45c1e3a91798056b66391e5c9949631c239aaab8ae5b785adc96c6a",
      "line": 298,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Increased presence of activated glial cells presenting elevated NF-κB and HLA-DR expression are commonly observed around the Aβ plaques in postmortem AD tissue",
      "key": "2aa3a0342a4d6df6e114df4ac6738b255e0cdf57f4dbe17f80078d43c859b6afc37b97f76eebc6cf36448d4503206c1e28795551bd282eb8dc319be2de67b25b",
      "line": 290,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 9
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "47310515b9025761fca3275bf7915785a123afaedb19fe7df6f1439984b56ca119c4c087aa9fe1a98ece64a3f2b7fe86238b19478fe228578e0600f741cc9e77",
      "line": 299,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 55
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "4932cb1ec45ebe59c0e55b5120422951e49f9a91861b4f381f0a7c779d43cdd4f7abd57f3be07ff75db180a61c859977874a68f1040a2d3444befcf1e90a5179",
      "line": 300,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 56
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "224e7d172e5c7f1709768a20d3b3eca3138d6e1b85e96b355489acfb4cb81374e6d087b53b6ef2323bcae8cb73caa3f48955b82d3679c31432a590e7baa46743",
      "line": 301,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 63
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "e840dc9773990a8bf388c1476d272fe0be7a5f6e33243191b8d1737d71e43570b0e3c20afcb22fd388bba10f30067aa1613fcaaa18e4e0fc9b97d296a7514481",
      "line": 320,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 37
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "d4fff57287868dcad2c49be630b060ece55fc8921b3ba00377b3776752e7e16a457256189450c4d7300e774c527db25ce65dfa3fc2fcd524e6e5db18d01a1633",
      "line": 322,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 42
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "41a4616993b431a052e29581848ab4b4c08d77b3bed34aceb93a8b3efc95279b9006dc00c05f436bc505e196c588ea89e8563449439d14242d4d8b48bbbe203f",
      "line": 324,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 38
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "e1cf1b9a6a9ca9697779b429dd40e67b6d7a2923a9789ab70f4873698fc70e23cd818195670fe2622252335372d869b49b406ab5748eb11c7a583a57b0c730cb",
      "line": 326,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 39
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "7f39d7bab8d530b1f7e2a4808aa05b032f6d4425254dbfabd29919b538bfc9dbd8ef2b749d02662c07abd4edf6eb2d24adf12c1df0221cf4f8606a1e8e33b20f",
      "line": 328,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 40
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "b1b641499d2fab4c0dfb9a51f72cbbbed9e87ae66d12cdc61cf32533bed6e3b4bf0bd4e49025cb59cb9b707c372885964ea9234634e28d1e60b61884d9136010",
      "line": 330,
      "relation": "positiveCorrelation",
      "source": 68,
      "target": 41
    },
    {
      "key": "35d38722a413bb8952d70d953431f549f23a0bb06463d07eac5afd7d02a40886be9cb52e656e6285e5e48b70fc63d1a01175c571274cbd37bcd30a8ddac01dcd",
      "relation": "hasComponent",
      "source": 34,
      "target": 5
    },
    {
      "key": "ced7f6b6773a2db7a6453b38b7636f35236ced2fae4ccb133d3098ecaf1c82e93bcbd0d3d3ee7a0674d610b7e4dd11fe7ac75646322c6623c11613ebb368116b",
      "relation": "hasComponent",
      "source": 34,
      "target": 61
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": ". Consistent with the cellular studies, increased immunostaining for NF-κB-p65 has been observed in neurons and their processes in the hippocampal formation and entorhinal cortex in AD ",
      "key": "abb811d6e797cb1e7c7c4e4f00d7470e11fbe08ee76c7127c6153211c7c1205abdb798137829aed6424c58f5ff74d1631328a30f1b1eb4d285ee15bc211130c0",
      "line": 239,
      "relation": "positiveCorrelation",
      "source": 34,
      "target": 68
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "a4a4f33007c3807c5cd45438be6eefb7eacafb3539add45ea36a571a4a6eb9cdf92d06220b6449493f35ad34cea21708e63b4ac19b9ee144173609d306ad3ade",
      "line": 270,
      "relation": "positiveCorrelation",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "ef89dbe991ad011c185b79abda2e9d8490436e65aac2e5baa62b8bfcd00e564ce7393f92f854fe1efa5ae823ef5d69a1288c57c6cb92a958df3d297fa5d27037",
      "line": 272,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 24,
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "1dd929fc1150a8bdc16bc60aa90f70e9ede2d3bc1fcd2e3ddcf389f1cba67d7f780cd9301c7c467ab4d15c04d41b0d00bcb42344dfa9efb4843e4693808fc409",
      "line": 274,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 22,
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Excessive accumulation of Aβ1-42 stimulates microglial cells by signaling via receptor associated advanced glycation end products (RAGE) and peroxisome proliferator-activated receptor-γ (PPAR-γ), phosphorylates IKK proteins, and enhances NF-κB mediated transactivation of inflammatory cytokines and neurotoxic molecules such as glutamate and reactive oxygen species (ROS)/induced nitric oxide synthase (iNOS) [12] (Fig 2B)",
      "key": "4666aff242c9bf8e2fabd9289dc9373e02f45c87ddf2e4e9c8cbbece7d91f4ff71e85dd2352265acd6ad7941c23dd968f3ae5766dc23bdf7bcfb54d5da980438",
      "line": 276,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 66,
      "target": 14
    },
    {
      "key": "783db9204f2ccea8d8ad0933a87ec988ad246cbd4d12bb890f3b78fa7fcafbb694d9ed8f0b3e44a82682c769a1b9ffabfa764fd0b20cee6c88b0c97b36626f77",
      "relation": "hasVariant",
      "source": 65,
      "target": 66
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Increased presence of activated glial cells presenting elevated NF-κB and HLA-DR expression are commonly observed around the Aβ plaques in postmortem AD tissue",
      "key": "8a26796b2ee0dbd38d3415a673c5329687b0fd574b72f53953d8815377418e11bb25a1950613cf83bfdbe7ea3c05b8e68109b4915455711ef9d0f379663d2f8d",
      "line": 289,
      "relation": "association",
      "source": 9,
      "target": 69
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": " Increased presence of activated glial cells presenting elevated NF-κB and HLA-DR expression are commonly observed around the Aβ plaques in postmortem AD tissue",
      "key": "79431dd18dba162b784097a939c05279b1288b895638965fb3ff4b7f9d5a853e5acbc1247676d9e65aad82e8020485d76f6ae5d7c1375ce2146d3c74568d8712",
      "line": 290,
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 68
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "00b04d09f05ea82ac2b2ed9eb7b4163ae680bcc988f36dfb9fe514e8449a1b822479543aef8b5ab8b55aca72c8c5245af3b36f50b73ca204238e57b2beb93f42",
      "line": 299,
      "relation": "positiveCorrelation",
      "source": 55,
      "target": 68
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Increased presence of NF-κB mediated IL-1β, IL-6, and TNF-α cytokines have been reported in the affected tissues, serum and CSF of AD patients",
      "key": "d8558c209ebd0de94982e50dbd862c8df7eca8239326fb9561f4675db3022950b7bd5d53924cf1da1bd02b3b7d172842b77b27bfc8cf3de463cf9666a1df0adb",
      "line": 300,
      "relation": "positiveCorrelation",
      "source": 56,
      "target": 68
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "5d3b058a1229c60af822dc95e60125f153b91bd1d27b68c849596e858c19fdb11c68fd5c333d1e22f4af4ea48d795310735988375731f19d5c2742dc046e6c3d",
      "line": 320,
      "relation": "positiveCorrelation",
      "source": 37,
      "target": 68
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "da62a0a902f2e52ee857f2afb1f0ca97ecd73dd44e465f255d05e1ea01eb3a99b8d75808fa716f40bd2c76ffbce3f542d0adbd5c0f9b3ec2be3fa73872c5a2e9",
      "line": 322,
      "relation": "positiveCorrelation",
      "source": 42,
      "target": 68
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "9f67a1b7027e4219f705ad80364e17fbf73c38fa498a74cc5b67922b472f3f5ace0031453e593a9fc0dad5f4e22980abfce1388708d0b76c088a24df74a9836f",
      "line": 324,
      "relation": "positiveCorrelation",
      "source": 38,
      "target": 68
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "In AD brains, miRNA-125b is observed as the most abundant exhibiting strong positive correlation with glial fibrillary acidic protein and vimentin and negative correlation with reduced cyclin dependent kinase 2A",
      "key": "c98290dc4ddc52c8357d359854d2447f0431213d974f69c29efbf64e632dac9ceac8de2215f7b2701ab1a1c33f0d8287248dbfa277b0bfcd4b31af6d915ea724",
      "line": 338,
      "relation": "positiveCorrelation",
      "source": 38,
      "target": 53
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "In AD brains, miRNA-125b is observed as the most abundant exhibiting strong positive correlation with glial fibrillary acidic protein and vimentin and negative correlation with reduced cyclin dependent kinase 2A",
      "key": "cff7fbb8fd199bacb4c07ffcfaf3ee3062a967e1c840e982f181a48143e0eda41896a3b8f497e716eda1581e579175635791c4369352b74093060f83a699520e",
      "line": 339,
      "relation": "positiveCorrelation",
      "source": 38,
      "target": 64
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "In AD brains, miRNA-125b is observed as the most abundant exhibiting strong positive correlation with glial fibrillary acidic protein and vimentin and negative correlation with reduced cyclin dependent kinase 2A",
      "key": "d55370af2086614fc4c2b7362d20ce8f33998605c94829ce90023777bf1825083c3b13b684a42a68cff2fd56458c6ebeff3a1778f192bfee12ebdb42c113099b",
      "line": 340,
      "relation": "positiveCorrelation",
      "source": 38,
      "target": 52
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "9070a49617a1318e897ee76270c2835e0a05cacd017b2e0a3e7f65b4a82c516e7a6e1d277588d0513a7708a6ff4e7a0e71040173df41c05fca3902c47774f9f0",
      "line": 326,
      "relation": "positiveCorrelation",
      "source": 39,
      "target": 68
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "317d5782ca56bf480bb376c24331e3feb16758e56ffda77168f0aeb363696771a26dde53256be89cf30c6685c83cc1c5b0b2562a8d0d27649582b4f675c55851",
      "line": 328,
      "relation": "positiveCorrelation",
      "source": 40,
      "target": 68
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Neuroglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "Upregulation of several NF-κB regulated miRNAs such as miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, miRNA-155 and miRNA-339 5p have been observed in stressed primary human neuronalglial cells and in postmortem AD brain tissues",
      "key": "ce3ccef4cce5bd8b704328844ff28569c5c3ea7eb2ac21d1855dacb90c8a0b6a7dd82cb646d15dafff73fe98afecd095368a5b394c4bd7153e6454c6bed6bbc0",
      "line": 330,
      "relation": "positiveCorrelation",
      "source": 41,
      "target": 68
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "In AD brains, miRNA-125b is observed as the most abundant exhibiting strong positive correlation with glial fibrillary acidic protein and vimentin and negative correlation with reduced cyclin dependent kinase 2A",
      "key": "d948fc8a0419c200f4f61cb02302751b957a70aa21834d63ca832e104b4e79a3cf5c296f9a217931d62fd810e2a50da61bff5c7ddc3984f9a8a0988672863c36",
      "line": 338,
      "relation": "positiveCorrelation",
      "source": 53,
      "target": 38
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "In AD brains, miRNA-125b is observed as the most abundant exhibiting strong positive correlation with glial fibrillary acidic protein and vimentin and negative correlation with reduced cyclin dependent kinase 2A",
      "key": "aa040a702ead1ae12f25c7e206199012403a97e89854e060c126e1c9e379feb02569c4ca07b87fd324640d156d4fe35b53dafe8b7024251c5b6ca2f877a53d3e",
      "line": 339,
      "relation": "positiveCorrelation",
      "source": 64,
      "target": 38
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Lahiri DK",
          "Srinivasan M"
        ],
        "date": "2015-04-01",
        "first": "Srinivasan M",
        "last": "Lahiri DK",
        "name": "Expert opinion on therapeutic targets",
        "pages": "471-87",
        "reference": "25652642",
        "title": "Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.",
        "type": "PubMed",
        "volume": "19"
      },
      "evidence": "In AD brains, miRNA-125b is observed as the most abundant exhibiting strong positive correlation with glial fibrillary acidic protein and vimentin and negative correlation with reduced cyclin dependent kinase 2A",
      "key": "cbf22d20b10b1dee54391ee6c51f2c424a374c2d374d28f581803bbbc5602f4d930ff622b0011d85a26d23e8244fe6b0f573bb37c22887d8e8b1a38f24fe2545",
      "line": 340,
      "relation": "positiveCorrelation",
      "source": 52,
      "target": 38
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 42\")",
      "function": "Abundance",
      "id": "c2da54109c90719396dfdfb558be74582b8522863849a50f3f5029b7d60f4d53df3cfa1a97b787e760a2f74ea1f74012eb49273beeded42a2873d788953b4a13",
      "name": "amyloid-beta polypeptide 42",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "function": "Abundance",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
      "name": "amyloid-beta",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"glutamate(1-)\")",
      "function": "Abundance",
      "id": "fc1b84427efecfb8e3a837d65b6e115ffa8c7fc53ebacb54b967fd3aaafd25a6f47c147e986961e53c4ef1d5c36420fd9194019b5f81eeb5d33310f314818875",
      "name": "glutamate(1-)",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "function": "Abundance",
      "id": "5da7879846ec42231f9176e97a7f14c4b573807576fa75be6e3acb71f391f25971e33d2f7fb886003ebd8020ab592e1424e2fc106f91213d546078dd09fabb65",
      "name": "reactive oxygen species",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:peroxynitrite)",
      "function": "Abundance",
      "id": "fe63a43025ec98b86b63f7a0ff59747da6d8d6bdb82dd95d68e59448e6125933848846d8ba1dcb68dbe9928a6c904be0be53c06869cbc1844a302a0d9650304d",
      "name": "peroxynitrite",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(GO:\"NF-kappaB complex\")",
      "function": "Abundance",
      "id": "0d0402e877e230b7efc392263dc4d7b86196866e377d0dcc598b81779fa4240158f4315b874c040d34cc871d0765c465c5714aa65f802526d19059957ebf18f6",
      "name": "NF-kappaB complex",
      "namespace": "GO"
    },
    {
      "bel": "a(GO:\"neurofibrillary tangle\")",
      "function": "Abundance",
      "id": "3b50c674ff9633f408e5173562a06cf3a856abc95a8b034db8e940b464f1cea72df6f9fa9b7b02b5daf4eb86a37a155f203289451f7203a7b9c9e6c65313eadf",
      "name": "neurofibrillary tangle",
      "namespace": "GO"
    },
    {
      "bel": "a(MESH:\"Cholinergic Neurons\")",
      "function": "Abundance",
      "id": "475e93ca136a9e7794a0aa5f656e5e5514ae3be3984ee430b1c69e597fa87e955ab73e3aa428c790e154477727ce382f73ecadc9ea6ee58ce4366c0b4ed73765",
      "name": "Cholinergic Neurons",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Free Radicals\")",
      "function": "Abundance",
      "id": "692f2986e5bf67b94fdce1af0d0c8842584ac008d707b01f461dad50a6255417b8bf26adb78d451c2ef5d21d2136fb3feb67f6c5e74afe45881f4415243b4e42",
      "name": "Free Radicals",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"HLA-DR Antigens\")",
      "function": "Abundance",
      "id": "aa414ccffad9e3e480dd3255183972a5ec904d16eebc8412780bbd2a817a248d6369071de831c8be199ef14860d436b5414bd6095283ba7eecdada75d0ce98dd",
      "name": "HLA-DR Antigens",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"I-kappa B Proteins\")",
      "function": "Abundance",
      "id": "c2a797e0d2a14b9093d6f73348399b4ba9b344c5d7bf7121b5f207f6b20a2c151fb66983a2b2f95f6b7b366a7a5efdbaba524290de3a70938bd27bd6f7cd1083",
      "name": "I-kappa B Proteins",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Receptors, N-Methyl-D-Aspartate\")",
      "function": "Abundance",
      "id": "bc0c849274509856f0839b39c84ee4c4d06be886e9c4a160c019e566da4f7b7da0f773b5326d9d72ab53f350fa5ff3371b3cf66ae89e844579e4eb6102565963",
      "name": "Receptors, N-Methyl-D-Aspartate",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"amyloid beta-protein (25-35)\")",
      "function": "Abundance",
      "id": "27179ccb1680ada81aea0e2559b0fd6b5e25fddd805f1c005c521ca672e3d2e04619d93fe52797aeb0903971bb8148e5449cd64d6a6043a169b92bcfc795424d",
      "name": "amyloid beta-protein (25-35)",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Cytokines)",
      "function": "Abundance",
      "id": "b212e0151b8087a85aaf17315ce4d0ca06e7fa2700f3e41b10ea54a20d2484f11b545e768089b4d2b117a4feb6c7438ffd569bfaecfc5b5667807e6c2d637f93",
      "name": "Cytokines",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Microglia)",
      "function": "Abundance",
      "id": "02b5c9d69be012bcb43f05ec21f3168522e7cb682e90a7956b198540388c2652cc63707a9400288a6cf9ac7fe288615986eafce8e609e0871e97885e133245f9",
      "name": "Microglia",
      "namespace": "MESH"
    },
    {
      "bel": "bp(CONSO:\"APP processing\")",
      "function": "BiologicalProcess",
      "id": "62711cb0430d958ea1df74758e562e82ffbb815b3b9f5207a6675c49650e270d61dc34f2d7bdcce4859af35ff242b211f605dbcae46aa03b788fb8adc7114f7f",
      "name": "APP processing",
      "namespace": "CONSO"
    },
    {
      "bel": "bp(GO:\"apoptotic process\")",
      "function": "BiologicalProcess",
      "id": "1c5172472cbecf29eeb8e86a4cac2d13123fe572356f00e2f98302422560bbda2854e3b1f8fdf85396655393cf5ddb42e0db210c3d3fc146fa358cc8d0ed0254",
      "name": "apoptotic process",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"calmodulin dependent kinase signaling pathway\")",
      "function": "BiologicalProcess",
      "id": "452212b6882c4161a86e54f28ba66be6185377f02d3a8bf374263740fb8d9d17f81e5a1a83cfb42fc4d46c326a2e47cc1a9335ac22faa6641924713a4bf0dab8",
      "name": "calmodulin dependent kinase signaling pathway",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"cell death\")",
      "function": "BiologicalProcess",
      "id": "b2ecb9d87645a0a7d5efbe2c9eeeaa14a705a36b6cdf787e071ba334fdd12b4caaf12b88508b99a8974005549b3c8123c9481c5d969630df072082b07e4dc586",
      "name": "cell death",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "function": "BiologicalProcess",
      "id": "422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900",
      "name": "inflammatory response",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"membrane depolarization\")",
      "function": "BiologicalProcess",
      "id": "e39ac862551cfbabee553faf7cdf77b10d143e9ff3adb94c30b29266575efc988ceb9f023c9c3092ce7eb4f4f002154cd839d4a358db03ef35e2da80ced957f5",
      "name": "membrane depolarization",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "function": "BiologicalProcess",
      "id": "ad7c90f2bc746a5118759fd1c8857478c02207d574a26faaac9d6e4d6fa4661d8d87446139db0024a4011aae26027d3cabdfba663aec0ac0a8242868efb81dcd",
      "name": "neuron death",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"peroxisome proliferator activated receptor signaling pathway\")",
      "function": "BiologicalProcess",
      "id": "88d398c5912b3cc01967b04da2972d7a4315292e617eb187d38eaa853bfbbacd4fa040d667fefc985917fcbce247fbd77920388b5f8f703c49f76f2b3123f59d",
      "name": "peroxisome proliferator activated receptor signaling pathway",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"phosphatidylinositol 3-kinase signaling\")",
      "function": "BiologicalProcess",
      "id": "c5b50a642ca4efadb294e0b5efeb7c40ff5005bd0013ce20fcfd6b44c5447391dc746a43fd5d1615736f00cd05e8956e4dad1d982edbc25c1e9ed2dde8f0b70b",
      "name": "phosphatidylinositol 3-kinase signaling",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"positive regulation of advanced glycation end-product receptor activity\")",
      "function": "BiologicalProcess",
      "id": "e41ac3ee6e8b359f2a1cd53b7938cd48bcd1a42682ebdcb65791121859aede787625e98f75eaa0c301e79e7535889bb36f21d13996d5e91d6012cb1404ab8931",
      "name": "positive regulation of advanced glycation end-product receptor activity",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"positive regulation of synaptic plasticity\")",
      "function": "BiologicalProcess",
      "id": "050537bd5075eee0d80cf0fb0ffef9bde5982ad43aa3d08210f907971b9ed85d8eb4077a2e978f20841471f4d510b7f3cb6101d08c47d86d6ea352394b76e0ff",
      "name": "positive regulation of synaptic plasticity",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"synaptic transmission, glutamatergic\")",
      "function": "BiologicalProcess",
      "id": "68a9f5219c953044883133bf5f935c2f9a074b8e719aa33dc0766bba8dd98b92cefd134205b93bd6f586b594e1438d307a554c9771bccd03dc6acf03e09bb82c",
      "name": "synaptic transmission, glutamatergic",
      "namespace": "GO"
    },
    {
      "bel": "bp(MESH:\"Oxidative Stress\")",
      "function": "BiologicalProcess",
      "id": "32bd3ab5e8a3a26be3209856c88741f0f0e2dff98d2587599a6a21b0f4793c5d8feb1194ea2166cf3cece076e7095530b116270e6655bc8feb35a437fda42cf6",
      "name": "Oxidative Stress",
      "namespace": "MESH"
    },
    {
      "bel": "bp(MESH:\"Synaptic Transmission\")",
      "function": "BiologicalProcess",
      "id": "029ab128c5f88cb19d194601faa91ab7741b2fd933156dd2d47e360ce2f97abea415665dbac7bce169ccbcfd285c1628aacfeb15bb6ed2025876778dcc6b8360",
      "name": "Synaptic Transmission",
      "namespace": "MESH"
    },
    {
      "bel": "bp(MESH:Neuroprotection)",
      "function": "BiologicalProcess",
      "id": "4faae7cda7ea712ac9d9c27de14c6457cd84758cc7195c23f72e23fa92f07677fd6328b40deb0811b5e6fdda4375bc95095893a935493c67ad814bd89755e3b1",
      "name": "Neuroprotection",
      "namespace": "MESH"
    },
    {
      "bel": "complex(GO:\"NF-kappaB complex\")",
      "function": "Complex",
      "id": "3a4beef8af5f67742530b7b03a9535e4664bc86a324a25de89afd477ba2255b35861613031edeeed3c3779d3496452af049029d0be0a96abdb872b1dc261487a",
      "name": "NF-kappaB complex",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:\"NF-kappaB p50/p65 complex\")",
      "function": "Complex",
      "id": "8516b4f66c1ad2e24d94bc66063cf13c0e3a1e58124bb2a396a683a1f673ad6e8cf3b8e56c5adb2a52be334025b44503df4dcc83f90855917622a8c64d81c871",
      "name": "NF-kappaB p50/p65 complex",
      "namespace": "GO"
    },
    {
      "bel": "complex(a(GO:\"NF-kappaB complex\"), p(HGNC:NFKB1), p(HGNC:RELA))",
      "function": "Complex",
      "id": "dad7e78dc21b25579962fba8ccf9f002749b0912d0282051bb9aa8d715b3ad73f9064e12bfe5d69af44164ba0060d0dd202cb12b1345bde327bb57a26a5deac1",
      "members": [
        {
          "bel": "a(GO:\"NF-kappaB complex\")",
          "function": "Abundance",
          "id": "0d0402e877e230b7efc392263dc4d7b86196866e377d0dcc598b81779fa4240158f4315b874c040d34cc871d0765c465c5714aa65f802526d19059957ebf18f6",
          "name": "NF-kappaB complex",
          "namespace": "GO"
        },
        {
          "bel": "p(HGNC:NFKB1)",
          "function": "Protein",
          "id": "74e7c9867608715faaa5f4830a18e4dc77fa067db8c026e1686035b6fcf3fad3d5c832d4ee98a6ee44f9f3733039c270ada87a1b6166034833f69653618dd386",
          "name": "NFKB1",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:RELA)",
          "function": "Protein",
          "id": "02493376083b06f6044a237f4e756f227621391970d2c53693da442582176f53d992abe2f0fd0b28f8a305ab5f3429be4b4d20bd7fd4302ae88cf1eb87fe7e40",
          "name": "RELA",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(a(GO:\"NF-kappaB complex\"), p(HGNC:REL))",
      "function": "Complex",
      "id": "525e02a72d13774c034d1e0eb96af9cfadc1ce07115b2c330a41d54267f5d026f42ed0b7c76759fd8f20dcce52c2cd88ff81dc944365029a18587ae912bf1ad6",
      "members": [
        {
          "bel": "a(GO:\"NF-kappaB complex\")",
          "function": "Abundance",
          "id": "0d0402e877e230b7efc392263dc4d7b86196866e377d0dcc598b81779fa4240158f4315b874c040d34cc871d0765c465c5714aa65f802526d19059957ebf18f6",
          "name": "NF-kappaB complex",
          "namespace": "GO"
        },
        {
          "bel": "p(HGNC:REL)",
          "function": "Protein",
          "id": "7b6b7c58714bb705a13da15d67f438acebf34275cd0ea18b0b74f562ed34350154ff81fb09ef578e2b49fe2f95bd3e871b6f6467feab9c9d50778d7fc796835d",
          "name": "REL",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(a(GO:\"NF-kappaB complex\"), p(HGNC:RELA))",
      "function": "Complex",
      "id": "70bb300ca52a5076879038c210b9a56dc8826c70bdb2303ba33c1faf8e981234286bb4998e1aa6a903bafe6fa2682cd6001a6c6373598936c6a1f6bdef2eb5ac",
      "members": [
        {
          "bel": "a(GO:\"NF-kappaB complex\")",
          "function": "Abundance",
          "id": "0d0402e877e230b7efc392263dc4d7b86196866e377d0dcc598b81779fa4240158f4315b874c040d34cc871d0765c465c5714aa65f802526d19059957ebf18f6",
          "name": "NF-kappaB complex",
          "namespace": "GO"
        },
        {
          "bel": "p(HGNC:RELA)",
          "function": "Protein",
          "id": "02493376083b06f6044a237f4e756f227621391970d2c53693da442582176f53d992abe2f0fd0b28f8a305ab5f3429be4b4d20bd7fd4302ae88cf1eb87fe7e40",
          "name": "RELA",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:NFKB1), p(HGNC:RELA))",
      "function": "Complex",
      "id": "375c7d850cdc312eb3fdf20a49cd0aadc0c491379166c62f027159ada680f175a80a56f0277edc3df2bba7813c481459bfd97b9e9929fd0a704b438d9da5d07a",
      "members": [
        {
          "bel": "p(HGNC:NFKB1)",
          "function": "Protein",
          "id": "74e7c9867608715faaa5f4830a18e4dc77fa067db8c026e1686035b6fcf3fad3d5c832d4ee98a6ee44f9f3733039c270ada87a1b6166034833f69653618dd386",
          "name": "NFKB1",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:RELA)",
          "function": "Protein",
          "id": "02493376083b06f6044a237f4e756f227621391970d2c53693da442582176f53d992abe2f0fd0b28f8a305ab5f3429be4b4d20bd7fd4302ae88cf1eb87fe7e40",
          "name": "RELA",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "composite(a(MESH:\"amyloid beta-protein (25-35)\"), complex(GO:\"NF-kappaB complex\"))",
      "function": "Composite",
      "id": "44ecdf2cff535ae7df4555438a2b361e510ba4a723a116ea31ff04f6234ea319842995d54823a48f78e95805e85365de578a138419557c6be42f1c81dbcf6923",
      "members": [
        {
          "bel": "a(MESH:\"amyloid beta-protein (25-35)\")",
          "function": "Abundance",
          "id": "27179ccb1680ada81aea0e2559b0fd6b5e25fddd805f1c005c521ca672e3d2e04619d93fe52797aeb0903971bb8148e5449cd64d6a6043a169b92bcfc795424d",
          "name": "amyloid beta-protein (25-35)",
          "namespace": "MESH"
        },
        {
          "bel": "complex(GO:\"NF-kappaB complex\")",
          "function": "Complex",
          "id": "3a4beef8af5f67742530b7b03a9535e4664bc86a324a25de89afd477ba2255b35861613031edeeed3c3779d3496452af049029d0be0a96abdb872b1dc261487a",
          "name": "NF-kappaB complex",
          "namespace": "GO"
        }
      ]
    },
    {
      "bel": "m(HGNC:\"MIR9-1\")",
      "function": "miRNA",
      "id": "9dd3869a9568f35c6e14fdff222e0d48e1b8b41b3b3da9bd42aca787df5af8d0582b692efb39812646f9b5e4921d4469d8cf4727dbbc9c35f4f1025c73782393",
      "name": "MIR9-1",
      "namespace": "HGNC"
    },
    {
      "bel": "m(HGNC:MIR125B1)",
      "function": "miRNA",
      "id": "49b640ee78f75126256cb1fc6afe9bb485b4daac6315d7d1fcb4b8845cb5c516421cba08880179f3a58fcbdc8617fcfcfb06f9922c1ec78969ef4f8de96813f8",
      "name": "MIR125B1",
      "namespace": "HGNC"
    },
    {
      "bel": "m(HGNC:MIR146A)",
      "function": "miRNA",
      "id": "c72923fbb5f8cabc6b543292cb2c4b8c917632a09e264f0d4539b891b6dc4fc90cf96ee4aec3d10a6f7e9b3413a0d83e3bdb6b813b7538d5bcb5231acd0fa8a3",
      "name": "MIR146A",
      "namespace": "HGNC"
    },
    {
      "bel": "m(HGNC:MIR155)",
      "function": "miRNA",
      "id": "fedaac85db73171ebf5b58b04e55a60816877c4f7660f5dec05b0aeeb80c22c9a6c8b1b24a3cb0feae2f684d30476cf2f2f1e7b259641765701b2fe24203bc05",
      "name": "MIR155",
      "namespace": "HGNC"
    },
    {
      "bel": "m(HGNC:MIR339)",
      "function": "miRNA",
      "id": "86966188e92fa321a083b05f9c2a88bf2e797e01f4478dce98e69fb28ec56b159e10202a24ca8019077d9dc4f6bb9d24266f4d0a51f727d4d043a74cc5944db4",
      "name": "MIR339",
      "namespace": "HGNC"
    },
    {
      "bel": "m(HGNC:MIR34A)",
      "function": "miRNA",
      "id": "38686b144316b13e2da3e64bfc7a5afa3ce4681bb0c6bb2a988407bece1c394d16ba42f6941db902e8d4aebaeb62c4e24974af16d35c42556869166772e3c492",
      "name": "MIR34A",
      "namespace": "HGNC"
    },
    {
      "bel": "p(CONSO:\"sAPP-beta\")",
      "function": "Protein",
      "id": "5398d4984129759e9b240bafa6b1c68a4fa29a53cd3b11c8c3e9a0cf7ed4ad658837071ea10d874d9f67aa0a38eda520f01d74ce3462dcdcad62c2669f34828d",
      "name": "sAPP-beta",
      "namespace": "CONSO"
    },
    {
      "bel": "p(FPLX:PKC)",
      "function": "Protein",
      "id": "12137fadfdc5eb838cd33edabcf36ac0b775609d7303971d52755e1335928a559973fe26211ce3ac9a8599ee75c77a978b44d1d7114437a922a8911d9016aceb",
      "name": "PKC",
      "namespace": "FPLX"
    },
    {
      "bel": "p(HGNC:APOE)",
      "function": "Protein",
      "id": "b17ad2f45c20f323d56bf6d806eceebc45de815de6578a61f820329d5bba1059af52aa63bfcba2bea3b71985bc404e5fc1bce130012d3c58f3a39023923ffb43",
      "name": "APOE",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:APP)",
      "function": "Protein",
      "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc",
      "name": "APP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "function": "Protein",
      "id": "88f17e7dffb6947c01414f79e5a3bb9cdd3e932c355af7f0c8907d2b5d07742883eaf63866fe7fc938401ce0c366856fd5e306f324e6c1f474c1a984c8e46a51",
      "name": "BACE1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:BAX)",
      "function": "Protein",
      "id": "8a222b014ada3e5796ac04a4889d935c609db72c1e566d43b04ec45d9bddcabebc6a3a442ed1d12a5406ef159b7180dc656d8e99c2e5623af13bf85f2931bcae",
      "name": "BAX",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:BCL2)",
      "function": "Protein",
      "id": "b25decf9a9958e757d163c2d365729a1f86914126328ab0aabc90b2c29eb3a4617cd266432c4459745e2a1cd10176488cd1ba102d74f3869d82ad68257204b06",
      "name": "BCL2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:BCL2L1)",
      "function": "Protein",
      "id": "a70eccd68791bacccb175a7bbc2d053efb696d8a0cd0cc96b97125d4f45aec33a136204ff0cf307acdb13556cd95f89032f2ad13cfc6c6e1f7e112bc0549c18e",
      "name": "BCL2L1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:BDNF)",
      "function": "Protein",
      "id": "5bbeeb6a1045d125bd5495fbff1f4831c8697d0b4f9b77ff9f1127fd8bcf4d96eda74adab4e84332c6c9ba5bb97e102771278841e902a126ddbb438fddf7b8be",
      "name": "BDNF",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CDKN2A)",
      "function": "Protein",
      "id": "cc1b5025cb68807a41b72d2559258c330d00b7b5e5c2f88db1c6a7aca25f28ac9cabb8c2cc967ba1ceabbeef7e9aba618786ea9df5b2d5faf034097e368446aa",
      "name": "CDKN2A",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GFAP)",
      "function": "Protein",
      "id": "770dc5af3e4196536cabe720b408d7b24bb48c25eaa89cca048be9e87bed6118fbd749fb5c0b8b7814422fb430d364ec871f487b806b480765332568170c04b5",
      "name": "GFAP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GRM5)",
      "function": "Protein",
      "id": "55d1ed30d55bb5c980291c74d12a4bc55bdcc2874968bdb8348875a8d577eba2272331ab9e4f0d44aeea92f55cf52a2726fdb9d17c664b161416f9ad53335633",
      "name": "GRM5",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IL1B)",
      "function": "Protein",
      "id": "bd7736973dc00dadc09dff75214ff05344d2e9b6dfbc09a364f08b7cae84142149292551bd60d5addd6130e971c2ccd4c73b963ad918ad9b0a418b94e5a30cfd",
      "name": "IL1B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IL6)",
      "function": "Protein",
      "id": "51885c84a128c79b3473fbff464c7f04886821c78a7b0097d2e9fa942742f7586bf06c4fcce3776b98a284d6d0f0c669f1e6b0a029047df3f9f1549abf57ecba",
      "name": "IL6",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:NFKB1)",
      "function": "Protein",
      "id": "74e7c9867608715faaa5f4830a18e4dc77fa067db8c026e1686035b6fcf3fad3d5c832d4ee98a6ee44f9f3733039c270ada87a1b6166034833f69653618dd386",
      "name": "NFKB1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:NGF)",
      "function": "Protein",
      "id": "6280e1263996aa31e327521e5975bd06ec1fcc254924ed2e22ada8044eaafa6aeb9242e083f65427b4461e8f6a7d39b80be9b9a35d3509d266e3ced9c2b7afe4",
      "name": "NGF",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:NOS2)",
      "function": "Protein",
      "id": "b247a388978f9811ff9da74a67b691a4ded9ea5959a19112a001bd26f7a0c52b133b4937a2786b12f1c935f618a7f249b3f20beb200db000b10d85ebd06bf0ef",
      "name": "NOS2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:REL)",
      "function": "Protein",
      "id": "7b6b7c58714bb705a13da15d67f438acebf34275cd0ea18b0b74f562ed34350154ff81fb09ef578e2b49fe2f95bd3e871b6f6467feab9c9d50778d7fc796835d",
      "name": "REL",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:RELA)",
      "function": "Protein",
      "id": "02493376083b06f6044a237f4e756f227621391970d2c53693da442582176f53d992abe2f0fd0b28f8a305ab5f3429be4b4d20bd7fd4302ae88cf1eb87fe7e40",
      "name": "RELA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SOD2)",
      "function": "Protein",
      "id": "d9de7ac12e118486d41cd813025b0979125d0644f64cdbbd373bd89afb4806f4d51f9821124ddcc573517accdfb053ac846e20fec82ae07b7bfed58044bd3b44",
      "name": "SOD2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TNF)",
      "function": "Protein",
      "id": "a262f5edbfb734dd0ec9696a3b78644fccfb4054a9cf9225beb17c33ef416a75809ff59ec1646e29a3cccc804c9294f8d2c48120af9f5ee98e764a584626426d",
      "name": "TNF",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:VIM)",
      "function": "Protein",
      "id": "0175d06099092707c5547b687ffebddd68eb016458af0c791b674138dd75da31cd2572d9fe56e363bfe71a698650e2a12655f13dbf6a29566c84eeec69dbe6f5",
      "name": "VIM",
      "namespace": "HGNC"
    },
    {
      "bel": "p(MESH:\"I-kappa B Proteins\")",
      "function": "Protein",
      "id": "3e6f60fd785557f58b78689bda56e278419dad5623a86219f73e7a86e4e3a7580ea7e5ca82efbe7666cff59cc589e9570e76fe47023f3bb008ef2884d5ab2357",
      "name": "I-kappa B Proteins",
      "namespace": "MESH"
    },
    {
      "bel": "p(MESH:\"I-kappa B Proteins\", pmod(Ph))",
      "function": "Protein",
      "id": "9cd94304b07a7e02268dbf2e035096f7f7640a07910e4f56a1fe18a2f800ea4be05d784b494914f519f9e39015feb1bc87589694a068b6959ec5232d53801d24",
      "name": "I-kappa B Proteins",
      "namespace": "MESH",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "path(CONSO:neurotoxicity)",
      "function": "Pathology",
      "id": "402444c8075c3bd4b2a209c0756b87c8625726c4cfc69dd572f0a15c0a7067840791a25f05826f03ec0ea0dcf00ab468b9eb7f98f7b0637f76ef544893ce6952",
      "name": "neurotoxicity",
      "namespace": "CONSO"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "function": "Pathology",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541",
      "name": "Alzheimer Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Plaque, Amyloid\")",
      "function": "Pathology",
      "id": "888c33ecabc995942e605aace0106831b95c6e6d4eb99ee4ac4c1de25ff7c58c0cb67b5e941c2d3f3a399aada51a34de03850a43011389d2ab7dae07536cea30",
      "name": "Plaque, Amyloid",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Spatial Memory\")",
      "function": "Pathology",
      "id": "7617bc77b1deb949824e3cb1b4d2c858cd784ace0d2c41934e19bdeb43b399553629ec153ef25e9e2c80d2389dfc60de193a290e2fb966544d5769aba98f1358",
      "name": "Spatial Memory",
      "namespace": "MESH"
    }
  ]
}